Tregs with an MHC class II peptide–specific chimeric antigen receptor prevent autoimmune diabetes in mice
Adoptive immunotherapy with Tregs is a promising approach for preventing or treating type 1 diabetes. Islet antigen–specific Tregs have more potent therapeutic effects than polyclonal cells, but their low frequency is a barrier for clinical application. To generate Tregs that recognize islet antigen...
Main Authors: | Justin A. Spanier, Vivian Fung, Christine M. Wardell, Mohannad H. Alkhatib, Yixin Chen, Linnea A. Swanson, Alexander J. Dwyer, Matthew E. Weno, Nubia Silva, Jason S. Mitchell, Paul C. Orban, Majid Mojibian, C. Bruce Verchere, Brian T. Fife, Megan K. Levings |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Clinical Investigation
2023-09-01
|
Series: | The Journal of Clinical Investigation |
Subjects: | |
Online Access: | https://doi.org/10.1172/JCI168601 |
Similar Items
-
Tregs integrate native and CAR-mediated costimulatory signals for control of allograft rejection
by: Isaac Rosado-Sánchez, et al.
Published: (2023-10-01) -
Enhanced CD4+ and CD8+ T cell infiltrate within convex hull defined pancreatic islet borders as autoimmune diabetes progresses
by: Alexander J. Dwyer, et al.
Published: (2021-08-01) -
Tregs and Mixed Chimerism as Approaches for Tolerance Induction in Islet Transplantation
by: Shiva Pathak, et al.
Published: (2021-01-01) -
Interferon-γ Induced Expression of MHC Antigens Facilitates Identification of Donor Cells in Chimeric Transplant Recipients
by: Abdul S. Rao, et al.
Published: (1994-07-01) -
Chimeric Antigen Receptor (CAR) Treg: A Promising Approach to Inducing Immunological Tolerance
by: Qunfang Zhang, et al.
Published: (2018-10-01)